- Abbott Laboratories
- Overview
- Last Modified:
- April 9, 2025
- Company type:
- Public
- Industry:
- Healthcare
- Verified:
- No
- No of Employees:
- 100 001 +
- Stock Code:
- ABT
- Download
- Signed Health Status Declaration Form
- Turnover $50m + ?:
- Yes
- Headquarters:
- North Chicago, Illinois
- Public Interest Score:
- 750+
- Abbott Laboratories
- General Information
Description
Abbott Laboratories is a global healthcare company that develops and manufactures a broad range of medical devices, diagnostic tools, branded generic medicines, and nutritional products. It is known for its contributions to various medical fields, including diabetes care, cardiovascular health, diagnostics, and nutrition. The company was founded in 1888 by Dr. Wallace C. Abbott in North Chicago, Illinois, and has since grown into one of the largest healthcare companies in the world.
Abbott operates in over 160 countries and has a significant impact on global healthcare systems through its extensive product portfolio. It serves both developing and developed markets, working with hospitals, clinics, and individual consumers.
Key Areas of Focus:
-
Medical Devices: Abbott produces a wide array of devices for diagnosing and monitoring various conditions. This includes devices for diabetes management (like continuous glucose monitoring systems), cardiovascular devices, and other monitoring systems.
-
Diagnostics: Abbott is a major player in the diagnostic space, offering products for blood testing, molecular diagnostics, and point-of-care testing. These tools are essential for both hospitals and clinical labs to detect diseases and monitor health conditions.
-
Nutrition: The company produces nutrition products for both infants and adults, including products like infant formula, meal replacements, and nutritional supplements. Their well-known brands in this category include Similac and Ensure.
-
Pharmaceuticals: Abbott also has a strong presence in the branded generic medicines sector, offering medications across a range of therapeutic areas like gastrointestinal health, pain management, and women’s health.
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Dr Robert J. Alpern:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Dr Sally E. Blount:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Paola Gonzales:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Michelle Kumbier:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Darren Mcdew:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Nancy Mckinstry:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Michael Roman:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Daniel J. Starks:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
John Stratton:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Subsribe/ Login to view details on company risk rating
5 Benchmark > 4 Excellent > 3Â Good > 2 Caution > 1 Risk
- Company Information
- Company System Number:
- 14733
- Founded Year:
- 1888
- Registration Number:
- 36-0698440
- Country:
- United States of America
- Stock Exchanges:
-
- New York Stock Exchange
- Pakistan Stock Exchange
- Kazakhstan Stock Exchange
- BX Swiss
- Financial year end:
- December
- No. of Countries operations:
- 160
- Company Status:
- In Business
- Industry Sub Category:
- Drugs & Biotechnology
- Date listed on Stock Exchange:
- 01/01/1929
- Contact Information
- Business operation:
- From removing the regular pain of fingersticks as people manage their diabetes to connecting patients to doctors with real-time information monitoring their hearts, from easing chronic pain and movement disorders to testing half the world’s blood donations to ensure a healthy supply, our purpose is to make the world a better place by bringing life-changing health technologies to the people who need them. That’s our commitment to helping you live your best life.
- Primary office:
- 100 Abbott Park Road,Abbott Park Illinois, Chicago 60064-3500, USA
- Additional Information
- Listed?:
- Yes
- Company secretary:
- Reporting currency:
- USD
- ISIN number (12 digit):
NYSE
US0028241000PSX
PK0025701019KASE
US0028241000BXS
LU2384387564- Authorised shares:
- 2 400 000 000
- Issued shares:
- 1 987 883 852
- No of shareholders:
- 1001 and more shareholders
- No of shareholders holding 20%:
- 0 shareholders
- Number of shares traded
- Per Year:
- Per Quarter:
- Per Month:
Shareholders holding 5% +
For a comprehensive list, please contact InsidEntity.
Material Subsidiaries/Associates
For a comprehensive list, please contact InsidEntity.
Credit Rating
| Name | Logo | Country | Headquarters | Rating |
|---|---|---|---|---|
| Moody's | ![]() | United States of America | New York | Aa3 |
Countries Operations/ Offices
Company Directors
Claire
Non ExecutiveSally E.
Non ExecutiveMichelle
Non ExecutiveMichael
Executive
Directors Tenure
Director Experience
Company Auditors
Ernst & Young
Company Past Directors
Company Committees
|
Committee
|
Abbreviation
|
|---|---|
|
Supervisory Board
|
SB
|
|
Board
|
BD
|
|
Risk & Compliance
|
RC
|
|
Audit
|
AU
|
|
Remuneration
|
RE
|
|
Capital investment
|
CI
|
|
Industry Specific
|
IS
|
|
Nominations & Governance
|
NG
|
|
Health, Safety & Environment
|
HS
|
|
Social & Ethics
|
SE
|
|
Technology
|
TE
|
|
Executive
|
EX
|
|
Other
|
OT
|


